Crossmark Global Holdings Inc. Sells 5,303 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Crossmark Global Holdings Inc. trimmed its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 47.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,978 shares of the company's stock after selling 5,303 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in HealthEquity were worth $489,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its holdings in HealthEquity by 1.7% during the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company's stock worth $715,783,000 after buying an additional 149,133 shares in the last quarter. Clearbridge Investments LLC increased its stake in HealthEquity by 1.9% in the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company's stock valued at $204,915,000 after purchasing an additional 43,491 shares during the last quarter. Mackenzie Financial Corp increased its stake in shares of HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company's stock valued at $203,822,000 after acquiring an additional 325,906 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of HealthEquity by 8.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,547,402 shares of the company's stock worth $133,377,000 after acquiring an additional 115,841 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of HealthEquity by 0.8% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,122,057 shares of the company's stock valued at $96,721,000 after buying an additional 9,125 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Frank Corvino sold 1,039 shares of the company's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now owns 3,784 shares of the company's stock, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HQY shares. BTIG Research increased their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday. Barrington Research restated an "outperform" rating and set a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. Royal Bank of Canada reiterated an "outperform" rating and set a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. The Goldman Sachs Group began coverage on HealthEquity in a research note on Friday. They issued a "neutral" rating and a $108.00 target price on the stock. Finally, JMP Securities reissued a "market outperform" rating and issued a $105.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $107.23.

HealthEquity Stock Up 3.4 %

NASDAQ HQY traded up $3.28 during mid-day trading on Friday, hitting $98.98. The company's stock had a trading volume of 1,561,907 shares, compared to its average volume of 610,840. The firm has a market capitalization of $8.64 billion, a price-to-earnings ratio of 82.48, a PEG ratio of 1.55 and a beta of 0.52. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $101.17. The company's 50 day simple moving average is $85.02 and its 200 day simple moving average is $81.09.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.16. The company had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. Analysts anticipate that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.